(Q40989021)

25 September 2017

title

Indices of activity in rheumatic fever treated with corticosteroids (English)

1 reference

25 September 2017

0 references

WALKER CH

1

1 reference

25 September 2017

O'BRIEN D

2

1 reference

25 September 2017

GIBSON ML

3

1 reference

25 September 2017

IBBOTT FA

4

1 reference

25 September 2017

SWANZIGER JL

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1962

1 reference

The Journal of Pediatrics

25 September 2017

published in

1 reference

25 September 2017

volume

60

1 reference

25 September 2017

page(s)

815-822

1 reference

STUDIES ON THE MUCOPROTEINS OF HUMAN PLASMA. I. DETERMINATION AND ISOLATION.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

The quantitative estimation of cerebrosides in nervous tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Declining severity of rheumatic fever. A comparative study of the past four decades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Erythrocyte sedimentation rate, C-reactive protein determination, serum protein fractions, fibrinogen level and antistreptolysin reaction in 52 rheumatic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

The fibrinogen polymerization test in active rheumatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Acute phase reactants. I. Serum nonglucosamine polysaccharides in patients with rheumatic fever and related conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Acute phase reactants. II. Serum hexosamines in patients with rheumatic fever and related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Objective evaluation of patients with rheumatic diseases. III. Comparison of serum glycoprotein, seromucoid, and C-reactive protein determinations as methods for the evaluation of patients with rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

The serum polysaccharide-protein ratio (PR) as a measure of rheumatoid arthritis activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Short-term hormone therapy; its effect in active rheumatic carditis of varying duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Discrepancies in the erythrocyte-sedimentation test in rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

Determination of C-reactive protein in the blood as a measure of the activity of the disease process in acute rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

C-reactive protein in the chronic rheumatic diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2862%2980166-8

10.1016/S0022-3476(62)80166-8

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference